We’re tackling a wide array of compelling target opportunities with an approach that gives us the ability to discover best-in-class drugs in cancer and multiple other areas of high unmet medical need. We’d be nothing without a visionary team that not only pulls it all together, but is willing to stand behind an exciting novel approach.
Our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. We look for people who are committed to working together in a collaborative, rigorous and entrepreneurial culture. We’ve created the kind of work environment that not only gets, but keeps people excited and focused–and we’ve mastered the art of sharing our findings in ways that both educate and inspire. Putting protein motion at the heart of drug discovery will be a challenge, but we are confident that our team’s dedication and urgency will create opportunities that profoundly impact the lives of the patients we serve.
Headquartered in Cambridge, Mass., Relay Therapeutics is a private company launched with $57M Series A financing from Third Rock Ventures and from an affiliate of D. E. Shaw Research.
Relay invites extraordinarily creative, talented and passionate individuals to join us as we strive to make a difference in patients’ lives. We offer competitive compensation along with a comprehensive benefits package and we recognize the achievements of our employees. Our culture fosters collaboration and excellence. Join our team!
Relay Therapeutics was founded on the premise that protein motion can be leveraged to create breakthrough medicines. The team at Relay is putting this principle into practice, with the aim of accelerating the development of medicines that will make a transformative difference in patients’ lives. We’re tackling a wide array of compelling target opportunities with an approach that gives us the ability to discover best-in-class drugs in cancer and multiple other areas of high unmet medical need. We’d be nothing without a visionary team that not only pulls it all together, but is willing to stand behind an exciting novel approach.
Relay Therapeutics is seeking a pharmacology leader to enable the development of small molecule therapies for cancer and related diseases. The individual in this essential role will lead the design, external execution, and interpretation of in vivo pharmacology studies to support a growing pipeline of anti-cancer agents. The ideal candidate has broad and diverse experience with oncology and immuno-oncology models, has led in vivo studies to assess PK/PD/efficacy relationships, and has experience overseeing interactions with contract research organizations. Candidates must enjoy an interactive environment in which they will be asked to influence the strategy of multiple project teams.
Relay is seeking a highly motivated and well accomplished scientist to join our team. In this hands-on role, the Director, DMPK who will be responsible for:
Relay Therapeutics is seeking a self-motivated researcher a desire to excel at the highest level to join a team of scientists driving the discovery of novel small molecule therapeutics in oncology. The successful candidate will design and execute molecular and cell biology experiments focused on the discovery/validation of new drug targets, evaluation of candidate molecules, and development of novel biomarkers. A considerable level of independence is expected after the initial training period. S/he will interact and collaborate cross-functionally with scientists in other departments, including biochemists, chemists, and computational biologists. Significant project ownership will allow for acquisition of new skills and for learning additional facets of the drug discovery process as projects advance.
Relay Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
Pursuing groundbreaking medicines by focusing on protein motion.
Sustained urgency because patients can’t wait.
Openness through respect, listening, and speaking up.
Our best work, with passion, pride, and excellence.
Accomplishing great things through generosity, enthusiasm, and collaboration.